FORE Biotherapeutics Announces Oral Presentation of Phase 1/2a Plixorafenib Data
FORE Biotherapeutics to Present Plixorafenib Nonclinical Data Highlighting Potential Differentiation at the 2023 AACR-NCI-EORTC International Conference